{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:48:10Z","timestamp":1791924490447,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103111","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:44:11Z","timestamp":1791816251000},"page":"103111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Orally delivered metabolically reprogrammed probiotics for cascade-activated antitumor immunity in colorectal cancer"],"prefix":"10.1016","author":[{"given":"Lexuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichenxi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqiang","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-149X","authenticated-orcid":false,"given":"Zhongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103111_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq7248","article-title":"Cancer immunotherapy by \u03b3\u03b4 T cells","volume":"386","author":"Hayday","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","author":"Rosenberg","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.103111_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO-24-02081","article-title":"Chimeric Antigen Receptor-T Cells in Colorectal Cancer: Pioneering New Avenues in Solid Tumor Immunotherapy","volume":"43","author":"Ouladan","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.103111_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","article-title":"The immune microenvironment of colorectal cancer","volume":"25","author":"Kennel","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2020.10.040","article-title":"T-cell-based immunotherapy in colorectal cancer","volume":"498","author":"Feng","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.xcrm.2026.103111_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.103111_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103111_bib10","article-title":"Photoactivatable immunostimulatory nanoengineered microalgae for boosting cascade-activated antitumor immunity","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.103111_bib11","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103111_bib13","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: an update","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.103111_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202302508","article-title":"Augmenting Immunogenic Cell Death and alleviating myeloid-Derived suppressor cells by sono-activatable semiconducting polymer nanopartners for immunotherapy","volume":"35","author":"Ding","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103111_bib15","article-title":"Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.103111_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103111_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.01.029","article-title":"Chemotherapeutic drug delivery by tumoral extracellular matrix targeting","volume":"274","author":"Raav\u00e9","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.103111_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2021.09.025","article-title":"Cyclodextrins-modified metallic nanoparticles for effective cancer therapy","volume":"339","author":"Gandhi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.xcrm.2026.103111_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303542","article-title":"Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel","volume":"35","author":"Dai","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103111_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib21","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.103111_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcancer.2024.10.003","article-title":"Ferroptosis and immunosenescence in colorectal cancer","volume":"106\u2013107","author":"Wang","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2026.103111_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","article-title":"Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention","volume":"2","author":"Ho","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.103111_bib24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103111_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado8395","article-title":"Synthetic biology-driven induction of mature TLS formation enhances antitumor immunity in colorectal cancer","volume":"17","author":"Mi","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103111_bib26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.cmet.2025.03.012","article-title":"Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids","volume":"37","author":"Wang","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.103111_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Ni\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103111_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.172","article-title":"Bacterial flagellin-a potent immunomodulatory agent","volume":"49","author":"Hajam","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.103111_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.103111_bib31","article-title":"Impairing tumor metabolic plasticity via a stable metal-phenolicbased polymeric nanomedicine to suppress colorectal cancer","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103111_bib32","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib33","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw212","article-title":"Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties","volume":"363","author":"Sonnenborn","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.xcrm.2026.103111_bib35","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ibd.20377","article-title":"Clinical use of E. coli Nissle 1917 in inflammatory bowel disease","volume":"14","author":"Schultz","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.xcrm.2026.103111_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nm.4232","article-title":"Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth","volume":"23","author":"Cramer","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103111_bib38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103111_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103111_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412982","article-title":"Engineered bacteria manipulate cysteine metabolism to boost ferroptosis-based pancreatic ductal adenocarcinoma therapy","volume":"37","author":"Qiao","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.103111_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/cdd.2013.48","article-title":"Danger signalling during cancer cell death: origins, plasticity and regulation","volume":"21","author":"Garg","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2026.103111_bib42","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/febs.14818","article-title":"The extracellular matrix as a multitasking player in disease","volume":"286","author":"Theocharis","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.xcrm.2026.103111_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103111_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.103111_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccell.2025.12.005","article-title":"Cancer cell death: Cell-autonomous and immunogenic dimensions","volume":"44","author":"Galluzzi","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103111_bib46","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.103111_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103111_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40168-021-01071-4","article-title":"A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota","volume":"9","author":"Chung","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.xcrm.2026.103111_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103111_bib50","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1093\/oncolo\/oyae013","article-title":"The efficacy of immune checkpoint inhibitors in microsatellite stable colorectal cancer: A Systematic Review","volume":"29","author":"Guven","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.xcrm.2026.103111_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70004","article-title":"WNT2 blockade augments antitumor immunity by attenuating myeloid-derived suppressor cells in colorectal cancer","volume":"3","author":"Cui","year":"2024","journal-title":"MedComm\u2013Oncology"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:13:49Z","timestamp":1791922429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126005288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S2666379126005288"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103111","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally delivered metabolically reprogrammed probiotics for cascade-activated antitumor immunity in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103111"}}